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A B S T R A C T
Objectives
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:
To assess the eFects of psychological interventions delivered as a single component intervention on the management of overweight or
obesity in children and adolescents aged 6 to 17 years.
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B A C K G R O U N D
The prevalence of overweight and obesity in children and
adolescents is recognized as a global health concern aFecting
both high- and low-income countries (Cole 2000; Ng 2014). In
high-income countries, the prevalence of overweight and obesity
considered together using the International Obesity Task Force
(IOTF) definition is approximately 23.8% for boys and 22.6% in girls
(Ng 2014). In low- and middle-income countries, the prevalence is
approximately 12.9% for boys and 13.4% for girls (Ng 2014). The
WHO Childhood Obesity Surveillance Initiative (COSI) reported a
range in the prevalence of overweight and obesity between 18% to
57% for boys six to nine years and 18% to 50% among girls aged
six to nine years (Wijnhoven 2014). Furthermore, using the World
Health Organization (WHO) definition of obesity, the global age-
standardized prevalence of girls with obesity alone has increased
from 0.7% (0.4% to 1.2%) to 5.6% (4.8% to 6.5%) and from 0.9%
(0.5% to 1.3%) to 7.8% (6.7% to 9.1%) in boys over the past four
decades (NCD 2017). Although varying definitions of obesity (WHO,
IOTF, Centers for Disease Control and Prevention (CDC)) limit the
comparability of studies, it is apparent that the prevalence of
children and adolescents with overweight and obesity is high and
varies widely by age and geography.
Several factors may mediate the relationship between overweight
and obesity in children and adolescents. The prevalence of
children and adolescents with overweight or obesity varies by
sex, socioeconomic status (SES), and age within high- and low-
income regions (NCD 2017). For example, lower SES individuals in
high-income countries and higher SES individuals in low-income
countries are at greater risk of obesity (WHO 2016). Moreover,
COSI has identified that avoidable factors, such as urbanization
and economic development, are associated with overweight and
obesity in childhood (Djordjic 2016; Hassapidou 2017).
Additionally, there is a discrepancy in changing overweight and
obesity rates by country classification based on gross national
income. Whereas the rate of increase in children and adolescents
with overweight or obesity has slowed or ceased, particularly in
high-income countries, rates of overweight and obesity continue
to increase in many low-income countries (NCD 2017; Ng 2014;
Ogden 2016; Wabitsch 2014). Policy implementation contributes
to the decreasing rate of overweight and obesity in high-income
countries, which accentuates the disparities in resources and
interventions for the management of overweight and obesity (NCD
2017). However, despite the observed plateau in high-income
countries, the prevalence of overweight and obesity remains
high and future projections reinforce the global health burden
of overweight and obesity in childhood and adolescence; current
trends suggest that 57.3% of US American children and adolescents
2 to 19 years will be obese by the age of 35 (Ward 2017). Additionally,
predictions forecast that the combined global prevalence of
children aged 5 to 17.9 years with overweight and obesity will rise
from 13.9% in 2010 to 15.8% by 2025 (Lobstein 2016).
Description of the condition
Obesity is an accumulation of excess body weight, is
multifactorial in nature, and results from an interplay of genetic
predispositions, excess caloric intake, decreased physical activity,
and environmental factors (Silventoinen 2009). Overweight and
obesity in childhood imparts both short- and long-term health risks,
such as musculoskeletal concerns, cardiometabolic risk factors
such as hypertension, insulin resistance and dyslipidemia, (Kim
2017; Reilly 2003; Reilly 2011; Umer 2017), sleep apnea (Narang
2012), and may impact reproductive development (Solorzano
2010). Overweight or obesity during childhood can also impart
negative psychological consequences. Psychological factors, such
as depression, anxiety, emotional and behavioral problems, and
emotional overeating are associated with childhood overweight
and obesity (GriFiths 2010; Hebebrand 2009; Mallan 2017; Puder
2010). Additionally, overweight and obesity during childhood and
adolescence may contribute to stigmatization (Puhl 2008; Tang-
Peronard 2008), victimization (Hill 2017), and perceived low self-
worth in children and adolescents (GriFiths 2010; Hill 2017).
Description of the intervention
Psychological interventions are used as a stand-alone treatment
or in tandem with behavior-changing interventions ('lifestyle'
interventions), pharmacological, or surgical interventions to
reduce or obviate barriers for behavior change. They have been
employed in an attempt to achieve long-term maintenance
of behavioral change regarding weight loss and weight
loss maintenance (De Miguel-Etayo 2013). Yet, psychological
interventions vary in their approach. Behavioral therapies
are most common in weight management settings and are
designed to identify learned behaviors and use techniques
based on classical and operant conditioning to improve an
individual's functioning (LeLwich 2008). Cognitive therapies
focus on identifying dysfunctional and maladaptive thoughts
and changing these thoughts to promote improved functioning
(LeLwich 2008). Psychological interventions oLen draw from
multiple approaches and/or incorporate diFerent techniques, such
as cognitive-behavioral therapy (CBT), a variation of behavioral
therapy which addresses and modifies dysfunctional emotions,
thoughts, and behaviors (Lawyer 2008; Licht 2008). Third wave
CBT approaches such as acceptance and commitment therapy
(ACT) and compassion-focused therapy (CFT) draw on techniques
such as mindfulness and de-centering to change negative thought
patterns (Hayes 2004; O'Reilly 2014). In addition, motivational
interviewing is a method which evolved from person-centered
therapy and aims to resolve ambivalence and increase motivation
to initiate behavior changes (Armstrong 2011; Borrello 2015; Miller
2009). Psychological interventions also vary in their format and
setting. Common formats for psychological interventions include
individual, family, and group therapy, delivered in a clinic, school,
or community setting.
Adverse e4ects of the intervention
Adverse eFects of psychological interventions are not widely
discussed or reported. A past Cochrane review evaluating similar
treatments in adults found no adverse eFects of the intervention
(Shaw 2005), and a recent systematic review did not address
adverse eFects of psychological interventions (Bogle 2011). Two
recent reviews evaluating the impact of diet, physical activity
and behavioral interventions for the treatment of overweight and
obesity in children (Mead 2017) and adolescents (Al-Khudairy
2017), reported two and zero adverse eFects which were associated
with the intervention, respectively. The adverse eFects identified
in children included a significant reduction in body mass index
(BMI) and standardized BMI in a control participant (Croker 2012)
and cardiometabolic abnormalities (Kirk 2012) which were not
attributed to the behavioral aspect of the intervention. It is
plausible that a participant may experience an increase in anxiety
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or emotional distress resulting from delivery of a psychological
intervention. However, we presume this would be the identification
of pre-existing emotional distress and not the consequence of a
psychological intervention.
How the intervention might work
The intrinsic constituent of weight loss and weight management
in children and adolescents is the same as in adults (i.e.
reduction in energy intake and increase in energy expenditure).
The overarching objective of psychological interventions for
children and adolescents with overweight and obesity is to reduce
psychological barriers needed for behavior change supporting
weight loss, weight management or both. For example, successful
weight loss and maintenance may depend on adjusting coping
mechanisms in stressful situations, increasing self-eFicacy, and
improving self-awareness about eating behaviors, all of which
are therapeutic targets of psychological interventions (Elfhag
2005). A variety of psychological interventions have been used
for child and adolescent weight loss or weight maintenance
including CBT, motivational interviewing, and interpersonal
psychotherapy. How each psychological intervention might work
depends on the type of intervention and the target of the
intervention. For example, CBT uses a combination of behavioral
therapy techniques to modify behavior and cognitive techniques
to identify and change dysfunctional cognitions and beliefs
which are acting as a barrier to behavior change (Tsiros
2008). In contrast, motivational interviewing utilizes a variety
of approaches, such as reflective listening and shared decision-
making to assist individuals experiencing ambivalence towards
behavior change gain motivation (Resnicow 2006). Additionally,
psychological interventions can emphasize cognitive components
that may modify thinking processes, tackle distorted or inadequate
thoughts, and help develop problem-solving skills (Herrera 2004),
or behavioral components that may reduce excessive intake
and promote energy expenditure, thereby reducing body weight
(Epstein 2008; Herrera 2004; Luzier 2010). Moreover, cortisol, an
endocrinologic biomarker of stress, has been shown to moderate
the relationship between stress and adiposity (Michels 2015),
which provides evidence for a physiologic mechanism by which
reduced cortisol may lead to weight loss or weight management.
Hence, psychological interventions may reduce stress, improve
motivation and health-related quality of life, and therefore increase
the likelihood of success in behavioral changes needed for
the management of overweight and obesity. Although not all
children or adolescents with overweight and obesity experience
psychological distress (Hill 2017), psychological interventions may
also be eFective to motivate behavior change and support behavior
change maintenance.
Why it is important to do this review
The heightened prevalence of children and adolescents with
overweight and obesity is a global public health challenge with
both short- and long-term adverse physical and psychological
outcomes. Therefore, interventions which eFectively target short-
term weight loss or maintenance, and long-term behavior change
are imperative. The most recent Cochrane Reviews assessing
weight management in children and adolescents examined diet,
physical activity and behavioral interventions (Al-Khudairy 2017;
Colquitt 2016; Mead 2017), interventions delivered to parents
only (Loveman 2015), surgical (Ells 2015), and drug interventions
(Mead 2016) for the treatment of overweight or obesity in
children and adolescents. Multi-component interventions which
include a psychological component were evaluated in separate
Cochrane reviews (Al-Khudairy 2017; Mead 2017). However, the
eFicacy of single-component psychological interventions for
weight management in overweight and obese children and
adolescents has not been systematically assessed in a Cochrane
Review. Another review examined the eFect of psychological
interventions in the treatment of obesity in children, but it only
included studies up to 2008 (Bogle 2011). As a result, an up-to-date
review specifically evaluating psychological interventions in the
treatment of overweight and obesity in this population is needed.
O B J E C T I V E S
To assess the eFects of psychological interventions delivered as a
single component intervention on the management of overweight
or obesity in children and adolescents aged 6 to 17 years.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include RCTs, including cluster-randomized trials.
Types of participants
Participants are children or adolescents aged 6 to 17 years at
the commencement of the intervention. Trials involving children
or adolescents with obesity due to a secondary or syndromic
cause will be excluded. Trials involving participants with comorbid
disorders are eligible for inclusion as long as the intervention's
primary focus was to manage overweight and obesity.
Diagnostic criteria
Any diagnostic criteria that use a national or international growth
reference standard which incorporates sex and age for overweight
or obesity during childhood or adolescence will be accepted.
Given the heterogeneity in international definitions of overweight
and obesity, restricting the definition to one accepted reference
standard may lead to a geographical bias in the study selection. We
anticipate that most interventions will define overweight as a BMI-
for-age more than one standard deviation (SD) above a national
or internationally defined growth reference median, or at/above
the 85th percentile for height and age and that obesity will be
defined as a BMI-for-age more than two SDs above a national or
internationally defined growth reference median, or at/above the
95th percentile for height and age.
Types of interventions
We plan to investigate the following comparisons of intervention
versus control/comparator.
Intervention
We will include psychological interventions with the purpose of
weight loss or management, delivered as a single component
intervention. The psychological intervention will be delivered by
an individual, such as a psychologist or healthcare worker, who
is trained to deliver the intervention. We will include all types
of psychological interventions as long as the specific type of
intervention or therapy is clearly defined and can be identified,
such as psychotherapy, CBT, and motivational interviewing.
Psychological interventions delivered as a single component intervention for children and adolescents with overweight or obesity aged 6
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Comparisons
• No treatment or waiting-list control
• Usual care
Concomitant interventions will have to be identical in both the
intervention and comparator groups to establish fair comparisons.
If a trial includes multiple arms, we will include any arm that meets
the inclusion criteria for this review.
Minimum duration of intervention
There is no minimum duration of the intervention.
Minimum duration of follow-up
Minimum duration of follow-up will be six months from baseline.
We will define extended follow-up periods (open-label extension
studies) as follow-up of participants once the original trial, as
specified in the trial protocol, has been terminated.
Summary of specific exclusion criteria
• Trials that include children with a secondary or syndromic cause
of obesity.
• Interventions that include any form of pharmacotherapy as
a part of the intervention intended to modify weight or
metabolism.
• Trials in which the intervention is delivered solely to the parent.
• Trials designed to treat eating disorders.
• Trials with a follow-up duration of less than six months from
baseline.
• Trials that include a psychological intervention in a multi-
component intervention.
Types of outcome measures
We will not exclude a trial if it fails to report one or several of our
primary or secondary outcome measures. If none of our primary or
secondary outcomes is reported in the trial, we will not include the
trial but provide some basic information in the "Characteristics of
awaiting classification" table.
We will extract the following outcomes, using the methods and time
points specified below.
Primary outcomes
• Change in body weight and/or BMI
• Health-related quality of life (HRQoL)
• Adverse events
Secondary outcomes




• Psychosocial measures of well-being
• Intervention adherence and compliance
• Health-related behavior change
Method of outcome measurement
• Changes in body weight (kg) and/or BMI (kg/m2), measured but
not self-reported: BMI standardized unit (BMI z-score, or BMI
percentile for age).
• HRQoL: child- or parent-reported and evaluated by a validated
instrument such as CDC HRQoL–14 "Healthy Days Measure".
If multiple outcomes of HRQoL are reported, weight-specific
HRQoL will be selected in preference to general HRQoL.
• Adverse events: event defined as adverse that occurred
during or aLer the intervention, such as the referral of a
child or adolescent to additional mental health services not
incorporated into the intervention.
• Anthropometric measures other than change in body
weight or BMI: defined as any indicator of body mass
other than body weight or BMI measured using validated
anthropometry measurements such as skinfold thickness,
bioelectrical impedance, waist circumference, dual-energy X-ray
absorptiometry (DEXA).
• All-cause mortality: defined as death that occurred and was
recorded during or aLer the intervention.
• Morbidity: defined as illness or harm (e.g. diagnosis of a mental
health condition, eating disorder, or diabetes) associated with
the intervention.
• Socioeconomic eFects: defined as a validated measure of
socioeconomic status such as parental education or income
level.
• Psychosocial measures of well-being (mood and self-esteem):
evaluated by a validated instrument such as the Rosenberg
Self-Esteem Scale (RSES) and Mood and Feelings Questionnaire
(MFQ).
• Intervention adherence and compliance: defined as
investigator-documented adherence and compliance of
participants to the intervention.
• Health-related behavior change (including diet and physical
activity): defined as validated measures of diet or physical
activity.
Timing of outcome measurement
• Changes in measured body weight (kg) and/or BMI, HRQoL,
anthropometric measures other than change in body weight
or BMI, socioeconomic eFects, psychosocial measures of well-
being, health-related behavior change: measured at baseline
and any time point on or aLer six months' follow-up.
• Adverse events: measured at any time aLer participants were
randomized to intervention and comparator group.
• All-cause mortality, morbidity: measured at any time point
during follow-up.
• Intervention adherence and compliance: measured at each time
point per protocol to assess change.
Search methods for identification of studies
Electronic searches
We will search the following sources from the inception of each
database to the specified date and will place no restrictions on the
language of publication.
• Cochrane Central Register of Controlled Trials (CENTRAL) via the
Cochrane Register of Studies Online (CRSO);
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• MEDLINE Ovid (Epub Ahead of Print, In-Process & Other Non-
Indexed Citations, Ovid MEDLINE Daily and Ovid MEDLINE; from
1946 onwards);
• PsycINFO Ovid (1806 - present);
• LILACS (Latin American and Caribbean Health Science
Information database);
• ClinicalTrials.gov (www.clinicaltrials.gov); and
• World Health Organization International Clinical Trials Registry
Platform (ICTRP) (www.who.int/trialsearch/).
We will not include Embase in our search, as RCTs indexed in
Embase are now prospectively added to CENTRAL via a highly
sensitive screening process (Cochrane 2018).
For detailed search strategies, see Appendix 1. We continuously
apply an email alert service for MEDLINE via OvidSP to identify
newly published studies using the search strategy detailed in
Appendix 1.
Searching other resources
We will attempt to identify other potentially eligible trials or
ancillary publications by searching the reference lists of included
trials, systematic reviews, meta-analyses and health technology
assessment reports. In addition we will contact authors of included
trials to obtain additional information on the retrieved trials and
establish whether we may have missed further trials.
We will not use abstracts or conference proceedings for data
extraction because this information source does not fulfil the
CONSORT requirements which is "an evidence-based, minimum set
of recommendations for reporting randomized trials" (CONSORT
2018; Scherer 2018) unless full data are available from trial authors.
We will present information on abstracts or conference proceedings
in the 'Characteristics of studies awaiting classification' table. We
define grey literature as records detected in ClinicalTrials.gov or
WHO ICTRP.
Data collection and analysis
Selection of studies
Three of four review authors (LP, CB, HV, EG) will independently
screen the abstract, title or both, of every record we retrieve
in the literature searches in duplicate, to determine which trials
we should assess further. We will obtain the full text of all
potentially relevant records. We will resolve any disagreements
through consensus or by recourse to a fiLh review author (LE). If
we cannot resolve a disagreement, we will categorize the trial as
a 'study awaiting classification' and will contact the trial authors
for clarification. We will present an adapted PRISMA flow diagram
to show the process of trial selection (Liberati 2009). We will list all
articles excluded aLer full-text assessment in a 'Characteristics of
excluded studies' table and will provide the reasons for exclusion.
Data extraction and management
For trials that fulfil our inclusion criteria, three out of four review
authors (LP, CB, HV, EG) will independently extract key information
on participants, interventions and comparators. We will describe
interventions by use of the 'template for intervention description
and replication' (TIDieR) checklist (HoFmann 2014; HoFmann
2017).
We will report data on eFicacy outcomes and adverse events using
standardized data extraction sheets from the Cochrane Metabolic
and Endocrine Disorders Group. We will resolve any disagreements
by discussion or, if required, we will consult a fiLh review author
(LE).
We will provide information, including the trial identifier for
potentially relevant ongoing trials, in the 'Characteristics of
ongoing trials' table and in a joint appendix entitled 'Matrix of trial
endpoint (publications and trial documents)'. We will attempt to
find the protocol for each included trial and we will report in a joint
appendix the primary, secondary, and other outcomes from these
protocols, alongside the data from the study publications.
We will email all authors of included trials to enquire whether they
would be willing to answer questions regarding their trials. We will
present the results of this survey in an appendix. We will thereaLer
seek relevant missing information on the trial from the primary trial
author(s), if required.
Dealing with duplicate and companion publications
In the event of duplicate publications, companion documents or
multiple reports of a primary trial, we will maximize the information
yield by collating all available data and we will use the most
complete data set aggregated across all known publications. We
will list duplicate publications, companion documents, multiple
reports of a primary trial and trial documents of included trials
(such as trial registry information) as secondary references under
the study identifier (ID) of the included trial. Furthermore, we will
also list duplicate publications, companion documents, multiple
reports of a trial and trial documents of excluded trials (such as trial
registry information) as secondary references under the study ID of
the excluded trial.
Data from clinical trials registers
If data from included trials are available as study results in clinical
trials registers, such as ClinicalTrials.gov or similar sources, we will
make full use of this information and extract the data. If there is also
a full publication of the trial, we will collate and critically appraise
all available data. If an included trial is marked as a completed
study in a clinical trial register but no additional information (study
results, publication or both) is available, we will add this trial to the
table 'Characteristics of studies awaiting classification'.
Assessment of risk of bias in included studies
Three out of four review authors (LP, CB, HV, EG) will independently
assess the risk of bias for each included trial. We will resolve any
disagreements by consensus or by consulting a fiLh review author
(LE). In the case of disagreement, we will consult the remainder of
the review author team and make a judgment based on consensus.
If adequate information is unavailable from the publications, trial
protocols or other sources, we will contact the trial authors for more
detail to request missing data on 'Risk of bias' items.
We will use the Cochrane 'Risk of bias' assessment tool (Higgins
2019b), assigning assessments of low, high or unclear risk of bias
(for details see Appendix 2; Appendix 3). We will evaluate individual
bias items as described in the Cochrane Handbook for Systematic
Reviews of Interventions according to the criteria and associated
categorizations contained therein ( Higgins 2019b).
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We will present a 'Risk of bias' graph and a 'Risk of bias' summary
figure. We will distinguish between self-reported and investigator-
assessed and adjudicated outcome measures. We will consider the
following self-reported outcomes.
• Adverse events.
• Child- or parent reported HRQoL, self-esteem, and mood.
We will consider the following outcomes to be investigator-
assessed.
• Change in body weight or BMI.






Summary assessment of risk of bias
Risk of bias for a study across outcomes
Some risk of bias domains, such as selection bias (sequence
generation and allocation sequence concealment), aFect the risk
of bias across all outcome measures in a trial. In case of high risk
of selection bias, we will mark all endpoints investigated in the
associated trial as being at high risk. Otherwise, we will not perform
a summary assessment of the risk of bias across all outcomes for
a trial.
Risk of bias for an outcome within a study and across domains
We will assess the risk of bias for an outcome measure by including
all entries relevant to that outcome (i.e. both study-level entries and
outcome-specific entries). We consider low risk of bias to denote a
low risk of bias for all key domains, unclear risk to denote an unclear
risk of bias for one or more key domains and high risk to denote a
high risk of bias for one or more key domains.
Risk of bias for an outcome across studies and across domains
To facilitate our assessment of the certainty of evidence for key
outcomes, we will assess risk of bias across trials and domains
for the outcomes included in the 'Summary of findings' table. We
will define the evidence as being at low risk of bias when most
information comes from trials at low risk of bias, unclear risk of
bias when most information comes from trials at low or unclear
risk of bias, and high risk of bias when a suFicient proportion of
information comes from trials at high risk of bias.
Measures of treatment e4ect
When at least two included trials are available for a comparison
and a given outcome, we will try to express dichotomous data
as a risk ratio (RR) or odds ratio (OR), with 95% confidence
interval (CI). For continuous outcomes measured on the same scale
(e.g. weight loss in kg) we will estimate the intervention eFect
using the mean diFerence with 95% CI. For continuous outcomes
that measure the same underlying concept (e.g. HRQoL) but use
diFerent measurement scales, we will calculate the standardized
mean diFerence (SMD). We will express time-to-event data as a
hazard ratio (HR) with 95% CI.
Unit of analysis issues
We will take into account the level at which randomization
occurred, such as cross-over trials, cluster-randomized trials, and
multiple observations for the same outcome. If more than one
comparison from the same trial is eligible for inclusion in the same
meta-analysis, we will either combine groups to create a single
pairwise comparison or appropriately reduce the sample size so
that the same participants do not contribute data to the meta-
analysis more than once (splitting the 'shared' group into two or
more groups). While the latter approach oFers some solution to
adjusting the precision of the comparison, it does not account
for correlation arising from the same set of participants being in
multiple comparisons (Higgins 2019a).
We will attempt to reanalyze cluster-RCTs that have not
appropriately adjusted for potential clustering of participants
within clusters in their analyses. The variance of the intervention
eFects will be inflated by a design eFect. Calculation of a design
eFect involves estimation of an intra-cluster correlation coeFicient
(ICC). We will obtain estimates of ICCs through contact with authors
or impute them by using either estimates from other included
trials that report ICCs or external estimates from empirical research
(e.g. Bell 2013). We plan to examine the impact of clustering using
sensitivity analyses.
Dealing with missing data
If possible, we will obtain missing data from the authors of the
included trials. We will carefully evaluate important numerical
data such as screened, randomly assigned participants as well as
intention-to-treat, and as-treated and per-protocol populations.
We will investigate attrition rates (e.g. dropouts, losses to follow-up
and withdrawals), and we will critically appraise issues concerning
missing data and use of imputation methods (e.g. last observation
carried forward).
In trials where the SD of the outcome is not available at follow-up
or cannot be recreated, we will standardize by the average of the
pooled baseline SD from those trials that reported this information.
Where included trials do not report means and SDs for outcomes
and we do not receive the necessary information from trial authors,
we will impute these values by estimating the mean and variance
from the median, range, and the size of the sample (Hozo 2005).
We will investigate the impact of imputation on meta-analyses by
performing sensitivity analyses and we will report per outcome
which trials were included with imputed SDs.
Assessment of heterogeneity
In the event of substantial clinical or methodological heterogeneity,
we will not report trial results as the pooled eFect estimate in a
meta-analysis.
We will identify heterogeneity (inconsistency) by visually inspecting
the forest plots and by using a standard Chi2 test with a significance
level of α = 0.1 (Deeks 2019). In view of the low power of
this test, we will also consider the I2 statistic, which quantifies
inconsistency across trials to assess the impact of heterogeneity on
the meta-analysis (Higgins 2002; Higgins 2003). When we identify
heterogeneity, we will attempt to determine the possible reasons
for it by examining individual characteristics of the trial and
subgroup.
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Assessment of reporting biases
If we include 10 or more trials that investigate a particular
outcome, we will use funnel plots to assess small-trial eFects.
Several explanations may account for funnel plot asymmetry,
including true heterogeneity of eFect with respect to trial size,
poor methodological design (and hence bias of small trials) and
selective non-reporting (Kirkham 2010). Therefore we will interpret
the results carefully (Sterne 2011).
Data synthesis
We plan to undertake (or display) a meta-analysis only if we
judge the participants, interventions, comparisons, and outcomes
to be suFiciently similar to ensure a result that is clinically
meaningful. Unless good evidence shows homogeneous eFects
across trials of diFerent methodological quality, we will primarily
summarize data that are of low risk of bias using a random-
eFects model (Wood 2008). We will interpret random-eFects meta-
analyses with due consideration to the whole distribution of eFects
and present a prediction interval (Borenstein 2017a; Borenstein
2017b; Higgins 2009). A prediction interval needs at least three
trials to be calculated and specifies a predicted range for the true
treatment eFect in an individual trial (Riley 2011). For rare events
such as event rates below 1%, we will use the Peto's odds ratio
method, provided that there is no substantial imbalance between
intervention and comparator group sizes and intervention eFects
are not exceptionally large. In addition, we will perform statistical
analyses according to the statistical guidelines presented in the
Cochrane Handbook for Systematic Reviews of Interventions (Deeks
2019).
Subgroup analysis and investigation of heterogeneity
We anticipate specific subgroups may modify the eFect of
psychological interventions on weight maintenance in children and
adolescents. We plan to carry out subgroup analyses for these,
including investigation of interactions (Altman 2003).
• Age (6 to 11 years, and 12 to 17 years based on mean age of study
group at baseline).
• Weight status at baseline, defined as being above or below
severe obesity. Severe obesity is defined as a BMI z-score of 2.67,
or ≥ 99th percentile of weight for age and height.
• Duration of intervention, defined as 0 to 12 months or greater
than 12 months.
• Length of post-intervention follow-up, defined as 6 to 12 months
follow-up, and post-interventional follow-up 12 months or
longer.
• Type of psychological intervention, defined as behavioral, CBT,
third wave CBT, motivational interviewing, and other.
• Mode of delivery, defined as family-delivered, group-delivered,
and child- or adolescent-only interventions.
• Intervention delivery setting, defined as at a hospital, in a clinic,
or in the community.
• Who delivers the intervention, defined as trained psychologists/
psychiatrists versus non-psychologists/psychiatrists.
• Socioeconomic status of the country of delivery, as defined by
the Human Development Index.
Sensitivity analysis
When applicable, we plan to explore the influence of important
factors on eFect sizes, by performing sensitivity analyses in which
we restrict the analyses to the following.
• Published trials.
• The eFect of risk of bias, as specified in the Assessment of risk of
bias in included studies section.
• Very long or large trials to establish the extent to which they
dominate the results.
We will use of the following filters, if applicable: diagnostic criteria,
imputation used, language of publication (English versus other
languages), source of funding (industry versus other), or country
(depending on data).
We will also test the robustness of results by repeating the analyses
using diFerent measures of eFect size (RR, OR, etc) and diFerent
statistical models (fixed-eFect and random-eFects models).
Certainty of the evidence
We will present the overall certainty of evidence for each outcome
specified below, according to the GRADE approach, which takes
into account issues related not only to internal validity (risk of bias,
inconsistency, imprecision, publication bias) and external validity
(such as directness of results). Two review authors (selected from
HV, LP, CB, EG, KS) will independently rate the certainty of evidence
for each outcome. We will resolve any diFerences in assessment by
discussion or consultation with a third researcher (LE).
We will include an appendix entitled 'Checklist to aid consistency
and reproducibility of GRADE assessments', to help with
standardization of the 'Summary of findings' tables (Meader 2014).
Alternatively, we will use the GRADEpro GDT soLware and will
present evidence profile tables as an appendix (GRADEproGDT
2015). We will present results for the outcomes as described
in the Types of outcome measures section. If meta-analysis is
not possible, we will present the results in a narrative format
in the 'Summary of findings' table. We will justify all decisions
to downgrade the quality of trials using footnotes, and we will
make comments to aid the reader's understanding of the Cochrane
Review when necessary.
'Summary of findings' table
We will present a summary of the evidence in a 'Summary of
findings' table. This will provide key information about the best
estimate of the magnitude of the eFect, in relative terms and as
absolute diFerences, for each relevant comparison of alternative
management strategies; the numbers of participants and trials
addressing each important outcome; and a rating of overall
confidence in eFect estimates for each outcome. We will create
the 'Summary of findings' table based on the methods described
in the Cochrane Handbook for Systematic Reviews of Interventions
(Schünemann 2019) using Review Manager 5 soLware (RevMan
2014).
Interventions presented in the 'Summary of findings' table will
be psychological interventions delivered as a single component
intervention. The comparators will be no treatment or waiting-list
control, and usual care.
Psychological interventions delivered as a single component intervention for children and adolescents with overweight or obesity aged 6
to 17 years (Protocol)









Cochrane Database of Systematic Reviews
We will report the following outcomes, listed according to priority.




5. Health-related behaviour change.
6. All-cause mortality.
7. Morbidity.
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6. (adipos* or obes*).tw.
7. (overweight* or over weight*).tw.




11. exp Behavior Therapy/
12. Counseling/
13. exp Directive Counseling/
14. exp School Health Services/
15. School Nursing/
16. psychotherap*.tw.
17. (psycho* adj3 (therap* or treatment* or intervention* or counsel* or support*)).tw.
18. (behav* adj3 (therap* or treatment* or intervention* or counsel*)).tw.
19. (cognitiv* adj3 (therap* or treatment* or intervention*)).tw.
20. (motivation* adj3 (counsel* or interview*)).tw.
21. ((acceptance or child cent* or client cent* or commitment* or compassion* or emotion* focus* or family* or focus* oriented or
group or insight or integrative or interpersonal or mindful* or nondirective or non directive or person cent* or persuasion or problem
focused or problem solving or psychodynamic or relax* or schema* or self control* or social skill* or socio environmental or socioen-
vironmental or solution focused or stress manage* or validation) adj3 therap*).tw.
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22. (counsel?ing or psychoanaly* or psychoeducat* or relaxation techni* or role play* or self analysis or sociotherap* or stress man-
ag* or support group*).tw.
23. (school nurs*).tw.
24. or/10-23
Part III: Obesity + Intervention
25. 9 and 24





30. (boy or boys or boyhood).tw.
31. girl*.tw.
32. (kid or kids).tw.




37. (teen* or preteen*).tw.




Part V: Part III AND IV
42. 25 and 41
Part VI: Study filter [ Lefebvre 2019 Cochrane Handbook RCT filter - sensitivity max. version without "drug therapy.fs" ]
43. randomized controlled trial.pt.







51. exp animals/ not humans/
  (Continued)
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52. 50 not 51
Part VII: Part V + Part VI
53. 42 and 52
Cochrane Central Register of Controlled Trials (Cochrane Register of Studies Online)
Part I: Obesity
1. MESH DESCRIPTOR Obesity
2. MESH DESCRIPTOR Obesity, Morbid
3. MESH DESCRIPTOR Obesity, Abdominal
4. MESH DESCRIPTOR Pediatric Obesity
5. MESH DESCRIPTOR Overweight
6. (adipos* OR obes*):TI,AB,KY
7. (overweight* OR over weight*):TI,AB,KY
8. (weight ADJ1 (reduc* OR control* OR manage* OR maint* OR loss)):TI,AB,KY
9. #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8
Part II: Intervention
10. MESH DESCRIPTOR Psychotherapy EXPLODE ALL TREES
11. MESH DESCRIPTOR Behavior Therapy EXPLODE ALL TREES
12. MESH DESCRIPTOR Counseling
13. MESH DESCRIPTOR Directive Counseling EXPLODE ALL TREES
14. MESH DESCRIPTOR School Health Services EXPLODE ALL TREES
15. MESH DESCRIPTOR School Nursing
16. psychotherap*:TI,AB,KY
17. (psycho* ADJ3 (therap* OR treatment* OR intervention* OR counsel* OR support*)):TI,AB,KY
18. (behav* ADJ3 (therap* OR treatment* OR intervention* OR counsel*)):TI,AB,KY
19. (cognitiv* ADJ3 (therap* OR treatment* OR intervention*)):TI,AB,KY
20. (motivation* ADJ3 (counsel* OR interview*)):TI,AB,KY
21. ((acceptance OR child cent* OR client cent* OR commitment* OR compassion* OR emotion* focus* OR family* OR focus* oriented
OR group OR insight OR integrative OR interpersonal OR mindful* OR nondirective OR non directive OR person cent* OR persuasion
OR problem focused OR problem solving OR psychodynamic OR relax* OR schema* OR self control* OR social skill* OR socio environ-
mental OR socioenvironmental OR solution focused OR stress manage* OR validation) ADJ3 therap*):TI,AB,KY
22. (counsel?ing OR psychoanaly* OR psychoeducat* OR relaxation techni* OR role play* OR self analysis OR sociotherap* OR stress
manag* OR support group*):TI,AB,KY
23. (school nurs*):TI,AB,KY
24. #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23
Part III: Obesity + Intervention
25. #9 AND #24
  (Continued)
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Part IV: Population [adapted from Leclercq 2013 ]
26. MESH DESCRIPTOR Adolescent
27. MESH DESCRIPTOR Child
28. MESH DESCRIPTOR Pediatrics
29. minors:TI,AB,KY
30. (boy OR boys OR boyhood):TI,AB,KY
31. girl*:TI,AB,KY
32. (kid OR kids):TI,AB,KY




37. (teen* OR preteen*):TI,AB,KY
38. (underage* OR under age*):TI,AB,KY
39. pubescen*:TI,AB,KY
40. p?ediatric*:TI,AB,KY
41. #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40
Part V: Part III AND IV






4. (adipos* or obes*).tw.
5. (overweight* or over weight*).tw.




9. exp Behavior Therapy/
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13. Support Groups/
14. psychotherap*.tw.
15. (psycho* adj3 (therap* or treatment* or intervention* or counsel* or support*)).tw.
16. (behav* adj3 (therap* or treatment* or intervention* or counsel*)).tw.
17. (cognitiv* adj3 (therap* or treatment* or intervention*)).tw.
18. (motivation* adj3 (counsel* or interview*)).tw.
19. ((acceptance or child cent* or client cent* or commitment* or compassion* or emotion* focus* or family* or focus* oriented or
group or insight or integrative or interpersonal or mindful* or nondirective or non directive or person cent* or persuasion or problem
focused or problem solving or psychodynamic or relax* or schema* or self control* or social skill* or socio environmental or socioen-
vironmental or solution focused or stress manage* or validation) adj3 therap*).tw.
20. (counsel?ing or psychoanaly* or psychoeducat* or relaxation techni* or role play* or self analysis or sociotherap* or stress man-
ag* or support group*).tw.
21. (school nurs*).tw.
22. or/8-21
Part III: Part I + Part II
23. 7 and 22
Part IV: Population [adapted from Leclercq 2013 ]
24. minors.tw.
25. (boy or boys or boyhood).tw.
26. girl*.tw.
27. (kid or kids).tw.




32. (teen* or preteen*).tw.




Part V: Part III AND IV
37. 23 and 36
Part VI: Study filter [ Eady 2008  "PsycInfo Search Strategies" filter - best sensitivity version]
38. control*.tw. OR random*.tw. OR exp Treatment/
Part VII: Part V + Part VI
39. 37 and 38
  (Continued)
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LILACS (iAHx)
((((MH:"Obesity" OR MH:"Obesity, Morbid" OR MH:"Obesity, Abdominal" OR MH:"Pediatric Obesity" OR MH:"Overweight" OR adi-
pos$ OR obes$ OR overweight$ OR "over weight" OR sobrepes$ OR "exceso de peso" OR "excesso de peso" OR "weight reduction"
OR "weight loss" OR "weight control" OR "control de peso") AND (MH:"Psychotherapy" OR MH:"Behavior Therapy" OR MH:"Coun-
seling" OR MH:"Family Therapy" OR MH:"School Health Services" OR MH:"School Nursing" OR terapia OR psycoterap$ OR orienta$))
OR (MH:"Obesity/psychology" OR MH:"Obesity, Morbid/psychology" OR MH:"Overweight/psychology")) AND (MH:"Adolescent" OR
MH:"Child" OR MH:"Pediatrics" OR minors OR boy OR boys OR girl$ OR kid OR kids OR child OR childs OR children$ OR childhood$ OR
childcare$ OR schoolchild$ OR escolar$ OR adolescen$ OR preadolescen$ OR juvenil$ OR juventud$ OR youth$ OR teen$ OR preteen$
OR underage$ OR pubescen$ OR paediatri$ OR pediatri$ OR joven$ OR jovem$ OR niños OR niñas OR crianca$ OR menin$ OR "menor
de edad" OR "menores de edad" OR "menor de idade" OR "menores de idade")) OR MH:"Pediatric Obesity/prevention & control" OR
MH:"Pediatric Obesity/therapy" OR MH:"Pediatric Obesity/psychology"
+ Controlled Clinical Trial
WHO ICTRP (Standard search)
(activated "Search for clinical trials in children")
obes* AND psycho* OR
obes* AND cognitiv* OR
obes* AND behavi* OR
obes* AND motivation* OR
obes* AND counsel* OR
obes* AND emotion* OR
overweight* AND emotion* OR
overweight* AND psycho* OR
overweight* AND cognitiv* OR
overweight* AND behavi* OR
overweight* AND motivation* OR
overweight* AND counsel* OR
overweight* AND emotion*
ClinicalTrials.gov (Expert search)
AREA[ConditionSearch] ( obese OR overweight OR obesity OR EXPAND[Concept] "weight reduction" OR EXPAND[Concept] "weight
control" OR EXPAND[Concept] "weight loss" OR EXPAND[Concept] "weight management" ) AND AREA[InterventionSearch] ( psy-
chotherapy OR EXPAND[Concept] "psycho therapy" OR psychotherapeutic OR psychotherapeutical OR psychological OR cognitive
OR behavioral OR behavioural OR behavior OR behaviour OR motivational OR counseling OR counselling OR acceptance OR commit-
ment OR compassion OR emotion OR focussed OR focused OR EXPAND[Concept] "problem solving" OR psychodynamic OR schema




Appendix 2. Assessment of risk of bias
 
Risk of bias domains
Random sequence generation (selection bias due to inadequate generation of a randomized sequence)
For each included trial, we will describe the method used to generate the allocation sequence in sufficient detail to allow an assess-
ment of whether it should produce comparable groups.
• Low risk of bias: the trial authors achieved sequence generation using computer-generated random numbers or a random numbers
table. Drawing of lots, tossing a coin, shuffling cards or envelopes, and throwing dice are adequate if an independent person per-
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formed this who was not otherwise involved in the trial. We will consider the use of the minimisation technique as equivalent to
being random.
• Unclear risk of bias: insufficient information about the sequence generation process.
• High risk of bias: the sequence generation method was non-random or quasi-random (e.g. sequence generated by odd or even date
of birth; sequence generated by some rule based on date (or day) of admission; sequence generated by some rule based on hospital
or clinic record number; allocation by judgment of the clinician; allocation by preference of the participant; allocation based on the
results of a laboratory test or a series of tests; or allocation by availability of the intervention).
Allocation concealment (selection bias due to inadequate concealment of allocation prior to assignment)
We will describe for each included trial the method used to conceal allocation to interventions prior to assignment and we will assess
whether intervention allocation could have been foreseen in advance of or during recruitment, or changed after assignment.
• Low risk of bias: central allocation (including telephone, interactive voice-recorder, web-based and pharmacy-controlled random-
ization); sequentially numbered drug containers of identical appearance; sequentially numbered, opaque, sealed envelopes.
• Unclear risk of bias: insufficient information about the allocation concealment.
• High risk of bias: used an open random allocation schedule (e.g. a list of random numbers); assignment envelopes used without
appropriate safeguards; alternation or rotation; date of birth; case record number; any other explicitly unconcealed procedure.
We will also evaluate trial baseline data to incorporate assessment of baseline imbalance into the 'Risk of bias' judgment for selec-
tion bias (Corbett 2014). Chance imbalances may also affect judgments on the risk of attrition bias. In the case of unadjusted analy-
ses, we will distinguish between trials that we rate as being at low risk of bias on the basis of both randomization methods and base-
line similarity, and trials that we judge as being at low risk of bias on the basis of baseline similarity alone (Corbett 2014). We will re-
classify judgments of unclear, low or high risk of selection bias as specified in Appendix 3.
Blinding of participants and study personnel (performance bias due to knowledge of the allocated interventions by partici-
pants and personnel during the trial)
We will evaluate the risk of detection bias separately for each outcome (Hróbjartsson 2013). We will note whether endpoints were
self-reported, investigator-assessed or adjudicated outcome measures (see below).
• Low risk of bias: blinding of participants and key study personnel was ensured, and it was unlikely that the blinding could have been
broken; no blinding or incomplete blinding, but we judge that the outcome is unlikely to have been influenced by lack of blinding.
• Unclear risk of bias: insufficient information about the blinding of participants and study personnel; the trial does not address this
outcome.
• High risk of bias: no blinding or incomplete blinding, and the outcome is likely to have been influenced by lack of blinding; blinding
of trial participants and key personnel attempted, but likely that the blinding could have been broken, and the outcome is likely to
be influenced by lack of blinding.
Blinding of outcome assessment (detection bias due to knowledge of the allocated interventions by outcome assessment
We will evaluate the risk of detection bias separately for each outcome (Hróbjartsson 2013). We will note whether endpoints were
self-reported, investigator-assessed or adjudicated outcome measures (see below).
• Low risk of bias: blinding of outcome assessment is ensured, and it is unlikely that the blinding could have been broken; no blinding
of outcome assessment, but we judge that the outcome measurement is unlikely to have been influenced by lack of blinding.
• Unclear risk of bias: insufficient information about the blinding of outcome assessors; the trial did not address this outcome.
• High risk of bias: no blinding of outcome assessment, and the outcome measurement was likely to have been influenced by lack of
blinding; blinding of outcome assessment, but likely that the blinding could have been broken, and the outcome measurement was
likely to be influenced by lack of blinding.
Incomplete outcome data (attrition bias due to amount, nature or handling of incomplete outcome data)
For each included trial and/or each outcome, we will describe the completeness of data, including attrition and exclusions from the
analyses. We will state whether the trial reported attrition and exclusions, and report the number of participants included in the
analysis at each stage (compared with the number of randomized participants per intervention/comparator groups). We will also
note if the trial reported the reasons for attrition or exclusion and whether missing data were balanced across groups or were related
to outcomes. We will consider the implications of missing outcome data per outcome such as high dropout rates (e.g. above 15%) or
disparate attrition rates (e.g. difference of 10% or more between trial arms).
• Low risk of bias: no missing outcome data; reasons for missing outcome data unlikely to be related to true outcome (for survival data,
censoring unlikely to introduce bias); missing outcome data balanced in numbers across intervention groups, with similar reasons
  (Continued)
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for missing data across groups; for dichotomous outcome data, the proportion of missing outcomes compared with observed event
risk was not enough to have a clinically relevant impact on the intervention effect estimate; for continuous outcome data, plausible
effect size (mean difference or standardized mean difference) among missing outcomes was not enough to have a clinically relevant
impact on observed effect size; appropriate methods, such as multiple imputation, were used to handle missing data.
• Unclear risk of bias: insufficient information to assess whether missing data in combination with the method used to handle missing
data were likely to induce bias; the trial did not address this outcome.
• High risk of bias: reason for missing outcome data was likely to be related to true outcome, with either imbalance in numbers or
reasons for missing data across intervention groups; for dichotomous outcome data, the proportion of missing outcomes compared
with observed event risk enough to induce clinically relevant bias in the intervention effect estimate; for continuous outcome data,
plausible effect size (mean difference or standardized mean difference) among missing outcomes enough to induce clinically-rele-
vant bias in observed effect size; 'as-treated' or similar analysis done with substantial departure of the intervention received from
that assigned at randomization; potentially inappropriate application of simple imputation.
Selective reporting (reporting bias due to selective outcome reporting)
We will assess outcome reporting bias by integrating the results of the appendix 'Matrix of trial endpoints (publications and trial doc-
uments)' (Boutron 2014; Jones 2015; Mathieu 2009), with those of the appendix 'High risk of outcome reporting bias according to the
Outcome Reporting Bias In Trials (ORBIT) classification' (Kirkham 2010). This analysis will form the basis for the judgment of selective
reporting.
• Low risk of bias: the trial protocol was available and all the trial's prespecified (primary and secondary) outcomes that were of
interest to this review were reported in the prespecified way; the study protocol was unavailable, but it was clear that the published
reports included all expected outcomes (ORBIT classification).
• Unclear risk of bias: insufficient information about selective reporting.
• High risk of bias: not all the trial's prespecified primary outcomes were reported; one or more primary outcomes were reported
using measurements, analysis methods or subsets of the data (e.g. subscales) that were not prespecified; one or more reported
primary outcomes were not prespecified (unless clear justification for their reporting was provided, such as an unexpected adverse
effect); one or more outcomes of interest in the Cochrane Review were reported incompletely so that we cannot enter them in a
meta-analysis; the trial report failed to include results for a key outcome that we would expect to have been reported for such a trial
(ORBIT classification).
Other bias
• Low risk of bias: the trial appears to be free from other sources of bias.
• Unclear risk of bias: there was insufficient information to assess whether an important risk of bias existed; insufficient rationale or
evidence that an identified problem introduced bias.
• High risk of bias: the trial had a potential source of bias related to the specific trial design used; the trial was claimed to be fraudulent;
or the trial had some other serious problem.
  (Continued)
 
Appendix 3. Selection bias decisions
 
Selection bias decisions for trials that reported unadjusted analyses: comparison of results obtained using method details














Baseline imbalances present for important prognostic variable(s) High riskUnclear methods Unclear risk
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Limited or no baseline details Unclear risk
Baseline imbalances present for important prognostic variable(s) Unclear risk b
Groups appear similar at baseline for all important prognostic vari-
ables
Low risk





ple, with robust allo-
cation concealment
Low risk
No baseline details Unclear risk
Baseline imbalances present for important prognostic variable(s) High risk
Groups appear similar at baseline for all important prognostic vari-
ables
Low risk
Limited baseline details, showing balance in some important prognos-
tic variablesc
Unclear risk





No baseline details High risk
aTaken from Corbett 2014; judgments highlighted in bold indicate situations in which the addition of baseline assessments would
change the judgment about risk of selection bias, compared with using methods reporting alone.
bImbalance identified that appears likely to be due to chance.
cDetails for the remaining important prognostic variables are not reported.
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